Schaasberg WP - Search Results

1

International collaborative study on the second EUROHEP HCV-RNA reference panel.

Damen M, Cuypers HT, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HG, Lelie PN. Damen M, et al. Among authors: schaasberg wp. J Virol Methods. 1996 Apr 26;58(1-2):175-85. doi: 10.1016/0166-0934(96)02011-3. J Virol Methods. 1996. PMID: 8783163

2

Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.

Bresters D, Cuypers HT, Reesink HW, Schaasberg WP, van der Poel CL, Mauser-Bunschoten EP, Houghton M, Choo QL, Kuo G, Lesniewski R, et al. Bresters D, et al. Among authors: schaasberg wp. Vox Sang. 1992;62(4):213-7. doi: 10.1111/j.1423-0410.1992.tb01201.x. Vox Sang. 1992. PMID: 1379394

3

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.

Bresters D, Cuypers HT, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN. Bresters D, et al. Among authors: schaasberg wp. J Med Virol. 1994 Jul;43(3):262-8. doi: 10.1002/jmv.1890430313. J Med Virol. 1994. PMID: 7931188 Clinical Trial.

4

Early antihepatitis C virus response with second-generation C200/C22 ELISA.

van der Poel CL, Bresters D, Reesink HW, Plaisier AA, Schaasberg W, Leentvaar-Kuypers A, Choo QL, Quan S, Polito A, Houghton M, et al. van der Poel CL, et al. Vox Sang. 1992;62(4):208-12. doi: 10.1111/j.1423-0410.1992.tb01200.x. Vox Sang. 1992. PMID: 1322611

5

Infectivity of blood seropositive for hepatitis C virus antibodies.

van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, Lelie PN. van der Poel CL, et al. Lancet. 1990 Mar 10;335(8689):558-60. doi: 10.1016/0140-6736(90)90347-8. Lancet. 1990. PMID: 1968574

6

Lack of immune potentiation by complexing HBsAg in a heat-inactivated hepatitis B vaccine with antibody in hepatitis B immunoglobulin.

Lelie PN, van Amelsfoort PJ, Martine de Groot CS, Bakker E, Schaasberg W, Niessen JC, Reesink HW. Lelie PN, et al. Hepatology. 1989 Jul;10(1):36-8. doi: 10.1002/hep.1840100109. Hepatology. 1989. PMID: 2737602 Clinical Trial.

7

Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands.

Van der Poel CL, Reesink HW, Mauser-Bunschoten EP, Kaufmann RH, Leentvaar-Kuypers A, Chamuleau RA, Schaasberg W, Bakker E, Exel-Oehlers PJ, Theobalds I, et al. Van der Poel CL, et al. Vox Sang. 1991;61(1):30-6. doi: 10.1111/j.1423-0410.1991.tb00923.x. Vox Sang. 1991. PMID: 1949707

8

Hepatitis B infection in infants after neonatal immunization.

Ip HM, Wong VC, Lelie PN, Reesink HW, Schaasberg W, Yeung CY, Ma HK. Ip HM, et al. Acta Paediatr Jpn. 1989 Dec;31(6):654-8. doi: 10.1111/j.1442-200x.1989.tb01374.x. Acta Paediatr Jpn. 1989. PMID: 2533786 Clinical Trial.

9

Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus.

Reesink HW, Lelie PN, Huisman JG, Schaasberg W, Gonsalves M, Aaij C, Winkel IN, van der Does JA, Hekker AC, Desmyter J, et al. Reesink HW, et al. Lancet. 1986 Aug 30;2(8505):483-6. doi: 10.1016/s0140-6736(86)90358-2. Lancet. 1986. PMID: 2875239

10

Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O.

Jongerius JM, van der Poel CL, van Loon AM, van den Akker R, Schaasberg W, van Leeuwen EF. Jongerius JM, et al. Transfusion. 1997 Aug;37(8):841-4. doi: 10.1046/j.1537-2995.1997.37897424408.x. Transfusion. 1997. PMID: 9280330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page